Metformin decreases the plasma concentration of pro-atherogenic metabolite trimethylamine N-oxide in an experimental model of type 2 diabetes

Activity: Talk or presentation typesOral presentation

Period24 Mar 2021
Event titleRSU Research week 2021: Knowledge for Use in Practice
Event typeConference
LocationRīga, Latvia
Degree of RecognitionInternational